Globe Life (GL) SVP and CAO reports stock option exercise, sale on 12/12/2025
Rhea-AI Filing Summary
Globe Life Inc. officer Michael Shane Henrie, the company’s SVP and Chief Accounting Officer, reported exercising stock options and selling common shares on 12/12/2025.
He exercised 3,065 employee stock options at an exercise price of $120.49 per share and sold 3,065 shares of Globe Life common stock at a weighted average price of $139.0997 per share, with sale prices ranging from $138.87 to $139.325. After these transactions, he directly owned 3,040 shares of common stock and indirectly held 154.904 shares through a 401(k) plan. The Form 4 also lists 3,065 employee stock options expiring on 02/22/2030, which were first exercisable as to 50% of the shares on 02/22/2025 and the remaining 50% on 02/22/2026.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Globe Life (GL) report on 12/12/2025?
The Form 4 reports that Michael Shane Henrie, an officer of Globe Life Inc., exercised 3,065 employee stock options and sold 3,065 shares of Globe Life common stock on 12/12/2025.
Who is Michael Shane Henrie in relation to Globe Life (GL)?
Michael Shane Henrie is listed as an officer of Globe Life Inc., serving as SVP & Chief Accounting Officer, and is the reporting person on this Form 4.
At what prices did Michael Shane Henrie exercise and sell Globe Life (GL) shares?
He exercised stock options at an exercise price of $120.49 per share and sold the resulting 3,065 shares at a weighted average price of $139.0997 per share, with individual sale prices ranging from $138.87 to $139.325.
How many Globe Life (GL) shares does Michael Shane Henrie own after the reported transactions?
Following the 12/12/2025 transactions, Michael Shane Henrie directly owned 3,040 shares of Globe Life common stock and indirectly held 154.904 shares through a 401(k) plan.
What stock options for Globe Life (GL) are reported for Michael Shane Henrie?
The Form 4 lists employee stock options with an exercise price of $120.49 per share and an expiration date of 02/22/2030, covering 3,065 shares of Globe Life common stock. These options were first exercisable as to 50% of the shares on 02/22/2025 and the remaining 50% on 02/22/2026.